CS
DGX icon

Credit Suisse’s Quest Diagnostics DGX Stock Holding History

Credit Suisse’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60,000
Closed -$10.4M – 3780
2021
Q4 		$10.4M Sell
60,000
-10,000
-14% -$1.52M 0.01% 1481
2021
Q3 		$10.2M Sell
70,000
-20,000
-22% -$2.93M 0.01% 1529
2021
Q2 		$12M Buy
+90,000
New +$11.8M 0.01% 1441
2019
Q2 		– Sell
-68,100
Closed -$6.12M – 4122
2019
Q1 		$6.12M Buy
+68,100
New +$5.9M 0.01% 1569

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse's DGX Position: Q1 2024 in Review

Credit Suisse reduced its Quest Diagnostics (DGX) stake by 4.4% in Q1 2024, selling an estimated $1.48M and leaving 244,718 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #496.

Credit Suisse first reported a position in DGX in Q2 2013 and has held it in 44 quarters since. The position peaked at $67M in Q3 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Credit Suisse held 244,718 shares of Quest Diagnostics worth $32.6M as of Q1 2024.
  • Credit Suisse sold 11,372 Quest Diagnostics shares in Q1 2024, an estimated $1.48M.
  • Quest Diagnostics made up 0.03% of Credit Suisse's portfolio in Q1 2024, its #496 holding.
  • Credit Suisse first reported a position in Quest Diagnostics in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Quest Diagnostics position peaked at $67M in Q3 2021.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.